Thrombolysis with 0.6 mg/kg intravenous alteplase for acute stroke in routine clinical practice: the outline of Japan post-Marketing Alteplase Registry Study (J-MARS) | Zendy

AI Assistant Blog Pricing

Thrombolysis with 0.6 mg/kg intravenous alteplase for acute stroke in routine clinical practice: the outline of Japan post-Marketing Alteplase Registry Study (J-MARS)

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.